Funding for this research was provided by:
National Institute of General Medical Sciences (P50 GM071508, GM0866465, GM081686)
Division of Cancer Epidemiology and Genetics, National Cancer Institute (1 R01 CA221296-01A1)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR070245, T32AR071307)
Pharmaceutical Research and Manufacturers of America Foundation (2007RSGl9572)
National Institutes of Health (UL1TR000124)
Melanoma Research Alliance (564714)
Cancer Research Institute
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles (Postdoctoral fellowship)
National Cancer Institute (T32 CA009056)
Eli and Edythe Broad Foundation (Rose Hills and Hal Gaba)
Rita Allen Foundation
National Science Foundation (DGE-0646086, OCI-1047879)
Leukemia and Lymphoma Society
Iris Cantor Women's Health Center
Received: 17 May 2018
Accepted: 25 September 2018
First Online: 25 October 2018
Ethics approval and consent to participate
: Human skin collection was approved by the Princeton University Institutional Review Board protocol number #3134. Informed consent was obtained by the National Disease Research Interchange. Animal experimentation was approved by the UCLA Office for Animal Research, protocol number 2015-033. All experimental methods comply with the Helsinki Declaration.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.